Exploring the association between khat use and psychiatric symptoms: a systematic review
- PMID: 35879018
- PMCID: PMC9328084
- DOI: 10.1136/bmjopen-2022-061865
Exploring the association between khat use and psychiatric symptoms: a systematic review
Abstract
Objectives: Consumption of the drug khat is high across East Africa and the South-Western Arabian Peninsula despite evidence for its adverse psychiatric effects. This systematic review aims to explore cross-sectional research in the field to determine the strength of the association between khat use and psychiatric symptoms METHODS: Six databases were searched in October 2021-Ovid Medline, Embase, APA PsycINFO, CINAHL, Scopus and Proquest-using the following search terms: "khat" OR "qat" OR "qaad" OR "catha" OR "miraa" OR "mairungi" AND "depression" OR "anxiety" OR "mania" OR "psych*" OR "schiz*" OR "mental" OR "hallucinations" OR "delusions" OR "bipolar". Eligible studies were cross-sectional studies of any population or setting comparing the prevalence of psychiatric symptoms in long term or dependent khat users with non-users. The quality of each study was appraised by the Newcastle-Ottawa scale. A meta-analysis was planned using a random effects model to produce an OR with 95% CIs-using the Mantel-Haenszel method-alongside an I2 statistic to represent heterogeneity. The quality of this meta-analysis was appraised using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) scoring system.
Results: 35 studies were eligible for inclusion (total participants=31 893), spanning 5 countries (Ethiopia, Somalia, Kenya, Saudi Arabia, UK). Meta-analysis suggests that khat use is associated with an 122% increased prevalence of psychiatric symptoms (OR 2.22, 95% CIs 1.76 to 2.79, p<0.00001, GRADE score: 'very low').
Conclusions: The high heterogeneity of the meta-analysis is likely due to the wide variation between the studies within the evidence base. To perform a more accurate systematic review, further primary studies are needed with standardised measurements of variables, particularly khat consumption.
Prospero registration number: CRD42020224510.
Keywords: adult psychiatry; mental health; psychiatry; public health; substance misuse.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
References
-
- European Monitoring Centre for Drugs and Drug Addiction . Khat drug profile (date unknown). Available: https://www.emcdda.europa.eu/publications/drug-profiles/khat/de [Accessed 01 Dec 2020].
-
- World Health Organisation . Khat chewing in Yemen: turning over a new leaf, 2008. Available: https://www.who.int/bulletin/volumes/86/10/08-011008/en/ [Accessed 01 Dec 2020]. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical